Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System

DOI record: { "DOI": "10.1001/jamanetworkopen.2022.10743", "ISSN": [ "2574-3805" ], "URL": "http://dx.doi.org/10.1001/jamanetworkopen.2022.10743", "author": [ { "affiliation": [ { "name": "Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York" }, { "name": "Department of Psychiatry, New York University Langone Medical Center, New York" } ], "family": "Nemani", "given": "Katlyn", "sequence": "first" }, { "affiliation": [ { "name": "Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York" } ], "family": "Williams", "given": "Sharifa Z.", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Psychiatry, Columbia University Irving Medical Center, New York, New York" } ], "family": "Olfson", "given": "Mark", "sequence": "additional" }, { "affiliation": [ { "name": "New York State Office of Mental Health, New York" } ], "family": "Leckman-Westin", "given": "Emily", "sequence": "additional" }, { "affiliation": [ { "name": "New York State Office of Mental Health, New York" } ], "family": "Finnerty", "given": "Molly", "sequence": "additional" }, { "affiliation": [ { "name": "New York State Office of Mental Health, New York" } ], "family": "Kammer", "given": "Jammie", "sequence": "additional" }, { "affiliation": [ { "name": "New York State Office of Mental Health, New York" } ], "family": "Smith", "given": "Thomas E.", "sequence": "additional" }, { "affiliation": [ { "name": "New York State Office of Mental Health, New York" } ], "family": "Silverman", "given": "Daniel J.", "sequence": "additional" }, { "affiliation": [ { "name": "Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York" }, { "name": "Department of Psychiatry, New York University Langone Medical Center, New York" } ], "family": "Lindenmayer", "given": "Jean-Pierre", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Psychiatry, New York University Langone Medical Center, New York" } ], "family": "Capichioni", "given": "Gillian", "sequence": "additional" }, { "affiliation": [ { "name": "Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York" } ], "family": "Clelland", "given": "James", "sequence": "additional" }, { "affiliation": [ { "name": "Nathan S. Kline Institute for Psychiatric Research, Orangeburg, New York" }, { "name": "Department of Psychiatry, New York University Langone Medical Center, New York" } ], "family": "Goff", "given": "Donald C.", "sequence": "additional" } ], "container-title": "JAMA Network Open", "container-title-short": "JAMA Netw Open", "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2022, 5, 6 ] ], "date-time": "2022-05-06T15:33:36Z", "timestamp": 1651851216000 }, "deposited": { "date-parts": [ [ 2022, 5, 6 ] ], "date-time": "2022-05-06T15:33:40Z", "timestamp": 1651851220000 }, "indexed": { "date-parts": [ [ 2022, 6, 3 ] ], "date-time": "2022-06-03T13:32:32Z", "timestamp": 1654263152211 }, "is-referenced-by-count": 1, "issue": "5", "issued": { "date-parts": [ [ 2022, 5, 6 ] ] }, "journal-issue": { "issue": "5", "published-print": { "date-parts": [ [ 2022, 5, 2 ] ] } }, "language": "en", "link": [ { "URL": "https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2791969/nemani_2022_oi_220321_1651174051.2345.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "10", "original-title": [], "page": "e2210743", "prefix": "10.1001", "published": { "date-parts": [ [ 2022, 5, 6 ] ] }, "published-online": { "date-parts": [ [ 2022, 5, 6 ] ] }, "publisher": "American Medical Association (AMA)", "reference": [ { "DOI": "10.1016/S2215-0366(21)00232-7", "article-title": "Mental disorders and risk of COVID-19–related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis.", "author": "Vai", "doi-asserted-by": "publisher", "first-page": "797", "issue": "9", "journal-title": "Lancet Psychiatry", "key": "zoi220321r1", "volume": "8", "year": "2021" }, { "DOI": "10.1001/jamanetworkopen.2020.23282", "article-title": "Association of a prior psychiatric diagnosis with mortality among hospitalized patients with coronavirus disease 2019 (COVID-19) infection.", "author": "Li", "doi-asserted-by": "publisher", "issue": "9", "journal-title": "JAMA Netw Open", "key": "zoi220321r2", "volume": "3", "year": "2020" }, { "DOI": "10.1001/jamanetworkopen.2021.34969", "article-title": "Analysis of COVID-19 infection and mortality among patients with psychiatric disorders, 2020.", "author": "Teixeira", "doi-asserted-by": "publisher", "issue": "11", "journal-title": "JAMA Netw Open", "key": "zoi220321r3", "volume": "4", "year": "2021" }, { "DOI": "10.1002/wps.v20.1", "article-title": "Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States.", "author": "Wang", "doi-asserted-by": "publisher", "first-page": "124", "issue": "1", "journal-title": "World Psychiatry", "key": "zoi220321r4", "volume": "20", "year": "2021" }, { "DOI": "10.1001/jamapsychiatry.2021.2274", "article-title": "Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis.", "author": "Fond", "doi-asserted-by": "publisher", "first-page": "1208", "issue": "11", "journal-title": "JAMA Psychiatry", "key": "zoi220321r5", "volume": "78", "year": "2021" }, { "DOI": "10.1001/jamapsychiatry.2020.4442", "article-title": "Association of psychiatric disorders with mortality among patients with COVID-19.", "author": "Nemani", "doi-asserted-by": "publisher", "first-page": "380", "issue": "4", "journal-title": "JAMA Psychiatry", "key": "zoi220321r6", "volume": "78", "year": "2021" }, { "DOI": "10.1093/schbul/sbab012", "article-title": "COVID-19 prevalence and mortality among schizophrenia patients: a large-scale retrospective cohort study.", "author": "Tzur Bitan", "doi-asserted-by": "publisher", "first-page": "1211", "issue": "5", "journal-title": "Schizophr Bull", "key": "zoi220321r7", "volume": "47", "year": "2021" }, { "DOI": "10.1001/jamapsychiatry.2020.0894", "article-title": "Addressing the COVID-19 pandemic in populations with serious mental illness.", "author": "Druss", "doi-asserted-by": "publisher", "first-page": "891", "issue": "9", "journal-title": "JAMA Psychiatry", "key": "zoi220321r8", "volume": "77", "year": "2020" }, { "DOI": "10.1001/jamapsychiatry.2021.2503", "article-title": "Association between antipsychotic use and COVID-19 mortality among people with serious mental illness.", "author": "Nemani", "doi-asserted-by": "publisher", "first-page": "1391", "issue": "12", "journal-title": "JAMA Psychiatry", "key": "zoi220321r9", "volume": "78", "year": "2021" }, { "DOI": "10.1126/science.abe9403", "author": "Gordon", "doi-asserted-by": "publisher", "journal-title": "Science", "key": "zoi220321r10", "year": "2020" }, { "DOI": "10.1016/j.encep.2020.05.006", "article-title": "Repurposing chlorpromazine to treat COVID-19: the reCoVery study.", "author": "Plaze", "doi-asserted-by": "publisher", "first-page": "169", "issue": "3", "journal-title": "Encephale", "key": "zoi220321r11", "volume": "46", "year": "2020" }, { "DOI": "10.3389/fphar.2021.652688", "article-title": "Fluvoxamine: a review of its mechanism of action and its role in COVID-19.", "author": "Sukhatme", "doi-asserted-by": "publisher", "journal-title": "Front Pharmacol", "key": "zoi220321r12", "volume": "12", "year": "2021" }, { "DOI": "10.1016/S2214-109X(21)00448-4", "article-title": "Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.", "author": "Reis", "doi-asserted-by": "publisher", "journal-title": "Lancet Glob Health", "key": "zoi220321r13", "year": "2022" }, { "DOI": "10.1001/jamanetworkopen.2021.33090", "article-title": "Mortality risk among patients with COVID-19 prescribed selective serotonin reuptake inhibitor antidepressants.", "author": "Oskotsky", "doi-asserted-by": "publisher", "issue": "11", "journal-title": "JAMA Netw Open", "key": "zoi220321r14", "volume": "4", "year": "2021" }, { "DOI": "10.1038/s41380-021-01021-4", "article-title": "Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study.", "author": "Hoertel", "doi-asserted-by": "publisher", "first-page": "5199", "issue": "9", "journal-title": "Mol Psychiatry", "key": "zoi220321r15", "volume": "26", "year": "2021" }, { "DOI": "10.1371/journal.pone.0247122", "article-title": "Observational study of haloperidol in hospitalized patients with COVID-19.", "author": "Hoertel", "doi-asserted-by": "publisher", "issue": "2", "journal-title": "PLoS One", "key": "zoi220321r16", "volume": "16", "year": "2021" }, { "DOI": "10.1007/s40261-021-01001-0", "article-title": "Observational study of chlorpromazine in hospitalized patients with COVID-19.", "author": "Hoertel", "doi-asserted-by": "publisher", "first-page": "221", "issue": "3", "journal-title": "Clin Drug Investig", "key": "zoi220321r17", "volume": "41", "year": "2021" }, { "DOI": "10.1016/j.schres.2022.01.035", "article-title": "Olanzapine, risperidone and quetiapine: do these atypical antipsychotics have a protective effect for SARS-CoV-2?", "author": "Prokopez", "doi-asserted-by": "publisher", "first-page": "140", "journal-title": "Schizophr Res", "key": "zoi220321r18", "volume": "241", "year": "2022" }, { "DOI": "10.1038/s41380-021-01222-x", "article-title": "Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties.", "author": "Stip", "doi-asserted-by": "publisher", "first-page": "7093", "issue": "12", "journal-title": "Mol Psychiatry", "key": "zoi220321r19", "volume": "26", "year": "2021" }, { "DOI": "10.1016/j.jcv.2020.104663", "article-title": "Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.", "author": "Maine", "doi-asserted-by": "publisher", "journal-title": "J Clin Virol", "key": "zoi220321r21", "volume": "133", "year": "2020" }, { "DOI": "10.1016/S1473-3099(20)30769-6", "article-title": "Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.", "author": "Yang", "doi-asserted-by": "publisher", "first-page": "203", "issue": "2", "journal-title": "Lancet Infect Dis", "key": "zoi220321r23", "volume": "21", "year": "2021" }, { "DOI": "10.1056/NEJMc2029354", "article-title": "Risk factors for SARS-CoV-2 in a statewide correctional system.", "author": "Kennedy", "doi-asserted-by": "publisher", "first-page": "2479", "issue": "25", "journal-title": "N Engl J Med", "key": "zoi220321r24", "volume": "383", "year": "2020" }, { "DOI": "10.1056/NEJMoa2005412", "article-title": "Epidemiology of Covid-19 in a long-term care facility in King County, Washington.", "author": "McMichael", "doi-asserted-by": "publisher", "first-page": "2005", "issue": "21", "journal-title": "N Engl J Med", "key": "zoi220321r25", "volume": "382", "year": "2020" }, { "DOI": "10.1080/07391102.2020.1802346", "article-title": "In silico identification of widely used and well-tolerated drugs as potential SARS-CoV-2 3C-like protease and viral RNA-dependent RNA polymerase inhibitors for direct use in clinical trials.", "author": "Gul", "doi-asserted-by": "publisher", "first-page": "6772", "issue": "17", "journal-title": "J Biomol Struct Dyn", "key": "zoi220321r26", "volume": "39", "year": "2021" }, { "DOI": "10.1016/j.psym.2020.05.025", "article-title": "Clozapine toxicity in the setting of COVID-19.", "author": "Dotson", "doi-asserted-by": "publisher", "first-page": "577", "issue": "5", "journal-title": "Psychosomatics", "key": "zoi220321r27", "volume": "61", "year": "2020" }, { "DOI": "10.1192/bjp.2020.151", "article-title": "Clozapine treatment and risk of COVID-19 infection: retrospective cohort study.", "author": "Govind", "doi-asserted-by": "publisher", "first-page": "368", "issue": "1", "journal-title": "Br J Psychiatry", "key": "zoi220321r28", "volume": "219", "year": "2021" }, { "author": "Okusaga", "journal-title": "J Clin Psychiatry", "key": "zoi220321r29", "year": "2021" }, { "DOI": "10.1016/j.schres.2021.06.019", "article-title": "An analysis of the possible protective effect of antipsychotics for SARS-CoV-2 in patients under treatment for severe mental illnesses.", "author": "Prokopez", "doi-asserted-by": "publisher", "first-page": "99", "journal-title": "Schizophr Res", "key": "zoi220321r30", "volume": "233", "year": "2021" }, { "DOI": "10.1007/978-3-030-39141-6", "article-title": "Inflammation, antipsychotic drugs, and evidence for effectiveness of anti-inflammatory agents in schizophrenia.", "author": "Pandurangi", "doi-asserted-by": "publisher", "first-page": "227", "journal-title": "Curr Top Behav Neurosci", "key": "zoi220321r31", "volume": "44", "year": "2020" }, { "DOI": "10.1016/j.ejphar.2021.173988", "article-title": "Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19.", "author": "Pitt", "doi-asserted-by": "publisher", "journal-title": "Eur J Pharmacol", "key": "zoi220321r32", "volume": "898", "year": "2021" }, { "DOI": "10.23937/2378-3516", "article-title": "Valproic acid in prevention and treatment of COVID-19.", "author": "Singh", "doi-asserted-by": "publisher", "first-page": "138", "journal-title": "Int J Respir Pulm Med", "key": "zoi220321r33", "volume": "7", "year": "2020" }, { "DOI": "10.2174/1389450121666201020154033", "article-title": "Downregulation of membrane-bound angiotensin converting enzyme 2 (ACE2) receptor has a pivotal role in COVID-19 immunopathology.", "author": "Vieira", "doi-asserted-by": "publisher", "first-page": "254", "issue": "3", "journal-title": "Curr Drug Targets", "key": "zoi220321r34", "volume": "22", "year": "2021" }, { "DOI": "10.1002/cpt.v110.6", "article-title": "Association between FIASMAs and reduced risk of intubation or death in individuals hospitalized for severe COVID-19: an observational multicenter study.", "author": "Hoertel", "doi-asserted-by": "publisher", "first-page": "1498", "issue": "6", "journal-title": "Clin Pharmacol Ther", "key": "zoi220321r35", "volume": "110", "year": "2021" }, { "DOI": "10.2105/AJPH.2021.306444", "article-title": "COVID-19 case rates after surveillance and vaccinations in a statewide psychiatric hospital system.", "author": "Smith", "doi-asserted-by": "publisher", "first-page": "1780", "issue": "10", "journal-title": "Am J Public Health", "key": "zoi220321r36", "volume": "111", "year": "2021" }, { "DOI": "10.1002/9781118548387", "author": "Hosmer", "doi-asserted-by": "crossref", "edition": "3rd ed", "key": "zoi220321r22", "volume-title": "Applied Logistic Regression", "year": "2013" }, { "key": "zoi220321r20", "unstructured": "US Food and Drug Administration. EUA authorized serology test performance. Accessed October 3, 2021. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/eua-authorized-serology-test-performance" } ], "reference-count": 36, "references-count": 36, "relation": {}, "resource": { "primary": { "URL": "https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2791969" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "General Medicine" ], "subtitle": [], "title": "Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State–wide Psychiatric Hospital System", "type": "journal-article", "volume": "5" }